Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Completed × ramosetron × Clear all
NCT00971399 2011-02-28

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Seoul National University Hospital

Phase 3 Completed
172 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡